Who Paid My Doc
Nascobal
Drug Prescription Supplement
NDC 49884-270-82
General payments
$258,701
Research payments
$0
Through program year 2024, $258,701 in general payments and $0 in research payments were reported against Nascobal (Prescription Supplement).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $1,099 | 62 |
| 2023 | General | $6,746 | 387 |
| 2022 | General | $17,315 | 1,029 |
| 2021 | General | $50,721 | 3,212 |
| 2020 | General | $57,072 | 3,006 |
| 2019 | General | $125,749 | 4,031 |
Breakdown
The top 5 of 54 recipients; each share is of general payments naming this product in 2024.
The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 10 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
11,727 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.